NewslettersHematopoiesis NewsUncategorizedLipase-Triggered Drug Release from BCL2 Inhibitor ABT-199-Loaded Nanoparticles to Elevate Anti-leukemic Activity through Enhanced Drug Targeting on the Mitochondrial MembraneBy Justin.choi - April 12, 20220133Researchers compared the anti-leukemic ability of pure ABT-199 and PEG-ABT-199 in vitro and in vivo.[Acta Biomaterialia] 6445212 BBBBBBBB items 1 apa 0 default asc 1 173899 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/AbstractGraphical Abstract